Therapeutic goods streamlining welcomed

Australia can streamline the regulation of therapeutic goods by removing duplicative and inefficient processes without undermining the safety and quality of medicines, the GBMA says following the Government's response to the Sansom Review.Many of the 32 recommendations of the Expert Review of Medicines and Medical Device Regulation would improve regulatory efficiency and deliver more timely